Hipro Biotechnology
Chinese POCT/IVD manufacturer with global distribution, specializing in immunoassay analyzers and diagnostic reagents for near-patient testing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Chinese POCT/IVD manufacturer with global distribution, specializing in immunoassay analyzers and diagnostic reagents for near-patient testing.
CardiovascularInflammationNephrologyEndocrinologyOncologyInfectious Disease
Technology Platform
Liquid-phase fluorescence immunoassay, lateral flow, and microfluidic chip platforms for automated and semi-automated point-of-care diagnostic testing.
Opportunities
Growth in emerging markets (Middle East, Asia) for decentralized testing, expansion of test menu on existing platforms, and increased adoption in primary care and home settings driven by telemedicine trends.
Risk Factors
Intense competition from global and local IVD players, pricing pressures, dependence on distributor networks, and the need for continuous regulatory re-certification and product innovation.
Competitive Landscape
Competes with global POCT leaders (e.g., Abbott, Roche, Siemens) and Chinese IVD companies; differentiates through a broad, cost-competitive CE-marked portfolio and a focus on accessibility for primary and remote care settings.